Correction: HLA Polymorphisms Are Associated With Treatment-Free Remission Following Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Mol Cancer Ther
.
2022 May 4;21(5):855.
doi: 10.1158/1535-7163.MCT-22-0146.
Authors
Hiroshi Ureshino
,
Takero Shindo
,
Hidenori Tanaka
,
Hiroh Saji
,
Shinya Kimura
PMID:
35506258
DOI:
10.1158/1535-7163.MCT-22-0146
No abstract available
Publication types
Published Erratum